Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics
José Daniel Subiela(Universidad de Alcalá), F.J. Burgos Revilla(Universidad de Alcalá), Giuseppe Basile(Vita-Salute San Raffaele University), J. Caño-Velasco(Hospital General Universitario Gregorio Marañón), Laura S. Mertens(Oncode Institute), Francesco Soria(Medical University of Vienna), Wojciech Krajewski(Wroclaw Medical University), David D‘Andrea(Medical University of Vienna), Juan Gómez Rivas(Medico), Luca Afferi(Universitat Autònoma de Barcelona), Andrea Gallioli(Puigvert Foundation), Tomasz Szydełko(Wroclaw Medical University), Benjamin Pradère, Karl H. Tully(Universitätsklinik Marien Hospital Herne), E. Lopez Perez(Universidad de Alcalá), Simone Albisinni(University of Rome Tor Vergata), Félix Guerrero‐Ramos(Research Institute Hospital 12 de Octubre), Mario Álvarez‐Maestro(Hospital Universitario La Paz), Miguel Ángel Jiménez Cidre(Universidad de Alcalá), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), Ekaterina Laukhtina(Sechenov University), Renate Pichler(Innsbruck Medical University), Daniel A. González‐Padilla(Clinica Universidad de Navarra), Andrzej Tukiendorf(Wroclaw Medical University), Óscar Rodríguez-Faba(Universitat Autònoma de Barcelona), Marco Moschini(Vita-Salute San Raffaele University), Guillaume Ploussard(Yves Rocher (France)), Júlia Aumatell(Puigvert Foundation), Javier Taborda(Universidad de Alcalá), Alejandra Serna Céspedes(Universidad de Alcalá), Francesco Del Giudice(Sapienza University of Rome), Jan Łaszkiewicz(Wroclaw Medical University), José L. Domínguez-Escrig(Fundación Instituto Valenciano de Oncología), M. Sánchez Encinas(Universidad Rey Juan Carlos), P. Del Olmo Duran(Universidad de Alcalá), Paweł Rajwa(University College London)
Cited by 20
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Towards a consensus on a hearing preservation classification system
|Acta Oto-Laryngologica|2013|222
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective
|Nature Reviews Urology|2022|196